-
1
-
-
33947541949
-
-
FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada. April 30 and May 1, 2002.
-
FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada. April 30 and May 1, 2002.
-
-
-
-
2
-
-
0035186405
-
Probiotics in the treatment and prevention of acute infectious diarrhoea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials
-
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhoea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; 33: S17-25.
-
(2001)
J Pediatr Gastroenterol Nutr
, vol.33
-
-
Szajewska, H.1
Mrukowicz, J.Z.2
-
3
-
-
33646713927
-
Efficacy of probiotics in prevention of acute diarrhea: A meta-analysis of masked, randomised, placebo-controlled trials
-
Sazawal S. Efficacy of probiotics in prevention of acute diarrhea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6: 374-82.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 374-382
-
-
Sazawal, S.1
-
5
-
-
0024652237
-
Réponse à la toxine cholérique de deux lignées de cellules épithé liales intestinales. Effet de Saccharomyces Boulardii
-
Czerucka D, Nano JL, Bernasconi P, Rampal P. Réponse à la toxine cholérique de deux lignées de cellules épithé liales intestinales. Effet de Saccharomyces Boulardii. Gastroenterol Clin Biol 1989; 13: 383-7.
-
(1989)
Gastroenterol Clin Biol
, vol.13
, pp. 383-387
-
-
Czerucka, D.1
Nano, J.L.2
Bernasconi, P.3
Rampal, P.4
-
6
-
-
0027516691
-
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
-
Pothoulakis C, Kelly CP, Joshi MA, Gao N, O'Keane CJ, Castagliuolo I, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-15.
-
(1993)
Gastroenterology
, vol.104
, pp. 1108-1115
-
-
Pothoulakis, C.1
Kelly, C.P.2
Joshi, M.A.3
Gao, N.4
O'Keane, C.J.5
Castagliuolo, I.6
-
7
-
-
0036286070
-
Experimental effects of Saccharomyces boulardii on diarrhoeal pathogens
-
Czerucka D, Rampal P. Experimental effects of Saccharomyces boulardii on diarrhoeal pathogens. Microbes Infect 2002; 4: 733-9.
-
(2002)
Microbes Infect
, vol.4
, pp. 733-739
-
-
Czerucka, D.1
Rampal, P.2
-
8
-
-
0027983624
-
Saccharomyces Boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines
-
Buts J De Keyser N, De Raedemaeker L. Saccharomyces Boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatric Res 1994; 36; 522-7.
-
(1994)
Pediatric Res
, vol.36
, pp. 522-527
-
-
Buts, J.1
De Keyser, N.2
De Raedemaeker, L.3
-
9
-
-
0025181832
-
Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine in rats treated with Saccharomyces boulardii
-
Buts JP Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine in rats treated with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 251-6.
-
(1990)
Dig Dis Sci
, vol.35
, pp. 251-256
-
-
Buts, J.P.1
Bernasconi, P.2
Vaerman, J.P.3
Dive, C.4
-
10
-
-
33645104228
-
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression
-
Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 2006; 343: 69-76.
-
(2006)
Biochem Biophys Res Commun
, vol.343
, pp. 69-76
-
-
Sougioultzis, S.1
Simeonidis, S.2
Bhaskar, K.R.3
Chen, X.4
Anton, P.M.5
Keates, S.6
-
11
-
-
23244467911
-
Saccharomyces boulardii: Basic science and clinical applications in gastroenterology
-
Buts JP Bernasconi P. Saccharomyces boulardii: basic science and clinical applications in gastroenterology. Gastroenterol Clin North Am 2005; 34: 515-32.
-
(2005)
Gastroenterol Clin North Am
, vol.34
, pp. 515-532
-
-
Buts, J.P.1
Bernasconi, P.2
-
12
-
-
12344272168
-
Effects of Saccharomyces boulardii in children with acute diarrhoea
-
Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005; 94: 44-7.
-
(2005)
Acta Paediatr
, vol.94
, pp. 44-47
-
-
Kurugol, Z.1
Koturoglu, G.2
-
13
-
-
0028306363
-
Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhoea
-
Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhoea. Ann Ped 1994; 41: 397-400.
-
(1994)
Ann Ped
, vol.41
, pp. 397-400
-
-
Cetina-Sauri, G.1
Sierra Basto, G.2
-
14
-
-
33747509612
-
Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea
-
Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, et al. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 2006; 12: 4557-60.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 4557-4560
-
-
Billoo, A.G.1
Memon, M.A.2
Khaskheli, S.A.3
Murtaza, G.4
Iqbal, K.5
Saeed Shekhani, M.6
-
15
-
-
0031880389
-
Management of acute diarrhoea with low osmolarity oral re-hydration solutions and Lactobacillus strain GG
-
Rautanen T, Isolauri E, Salo E, Vesikari T. Management of acute diarrhoea with low osmolarity oral re-hydration solutions and Lactobacillus strain GG. Arch Dis Child 1998; 79: 157-60.
-
(1998)
Arch Dis Child
, vol.79
, pp. 157-160
-
-
Rautanen, T.1
Isolauri, E.2
Salo, E.3
Vesikari, T.4
|